NPPA issued a notification regarding the fixation of the retail price of Vildagliptin (As Sustained Release) 100mg + Metformin Hydrochloride

Mar 05, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 04, 2024, issued a notification regarding the fixation of the retail price of Vildagliptin (As Sustained Release) 100mg + Metformin Hydrochloride.

The following has been stated: -

• Each uncoated bilayered tablet contains: Vildagliptin (As Sustained Release) 100mg + Metformin Hydrochloride IP (As Sustained Release) 500mg is 9.67.

[Notification No. 19(3882)/2024/DP/NPPA/Div.II I/7663/2024]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT